Produkty 330157-04-5

CAS 330157-04-5 występuje w naszej ofercie pod nazwami: Betamethasone EP Impurity F, Betamethasone Impurity 6（Betamethasone EP Impurity F）, 9-Desfluoro-11-deshydroxy-11,12-dehydro Betamethasone. Oferty producentów: Chemat Brand, Hubei YoungXin, TRC. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg.

Betamethasone EP Impurity F
Chemat Brand
  • opakowanie: on request
  • Warianty: 2
Zobacz produkt
Betamethasone Impurity 6（Betamethasone EP Impurity F）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
9-Desfluoro-11-deshydroxy-11,12-dehydro Betamethasone
TRC
  • opakowanie: 50mg
  • Warianty: 1
Zobacz produkt

(8S,9S,10R,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one (CAS 330157-04-5) to związek chemiczny o wzorze sumarycznym C22H28O4 i masie molowej 356.5 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one. InChIKey: ZPKPMZGRZVNGSU-OHIZPDRYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC22H28O4
Masa molowa356.5 g/mol
Nazwa IUPAC(8S,9S,10R,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one
InChIKeyZPKPMZGRZVNGSU-OHIZPDRYSA-N
SMILESC[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@H]3C=C[C@@]2([C@]1(C(=O)CO)O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 17,21-Dihydroxy-16beta-methylpregna-1,4,11-triene-3,20-dione, BETAMETHASONE IMPURITY F [EP IMPURITY], Pregna-1,4,11-triene-3,20-dioneE, 17,21-dihydroxy-16-methyl-, (16beta)-, BETAMETHASONE IMPURITY F (EP IMPURITY), Betamethasone EP Impurity F, 9-Desfluoro-11-deshydroxy-11,12-dehydro Betamethasone
Izomery (ten sam wzór sumaryczny)
1-(3,4-dimethoxyphenyl)-3-ethyl-5,6-dimethoxy-2-methyl-2,3-dihydro-1H-indene C22H28O4
[(6S,8R,9S,10R,13S,14S,17R)-17-ethynyl-6-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C22H28O4
(8S,10S,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one C22H28O4
(2Z)-2-hydroxy-2-[(6S,8S,9S,10R,11S,13S,14S)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]acetaldehyde C22H28O4
(1S,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-14-hydroxy-2,8,15-trimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C22H28O4
(1S,2S,10S,11S,13R,14R,15S,17S)-14-acetyl-14-hydroxy-2,13,15-trimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C22H28O4
(1S,2S,11S,13R,14S,15S,17S)-14-(2-hydroxyacetyl)-2,13,15-trimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C22H28O4
(6S,8S,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione C22H28O4
[(6R,8R,9S,10R,13S,14S,17R)-17-ethynyl-6-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C22H28O4
(8S,9S,10R,11R,13S,14S,17R)-11-hydroxy-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione C22H28O4
(2S,10S,11S,14R,15S)-14-acetyl-14-hydroxy-2,13,15-trimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C22H28O4
methyl 2-[(5-tert-butyl-2-methylphenyl)methoxymethyl]-6-methoxybenzoate C22H28O4